Researchers at the University of Oxford announced that a major leap in the implementation of a vaccine for the Corona virus, stressing that the vaccine may be ready on a large scale by next September. The researchers said that clinical trials on the vaccine against the emerging virus are well under way, noting that they are using a laboratory technique they have already used against other viruses in the past.
"Personally, I have a very high confidence in this vaccine, because I have already used this technique previously," Sarah Gilbert, a professor of vaccine science at Oxford, said in a report broadcast by CBS.
The technique is injecting the common cold influenza virus, after it has been neutralized and made non-spreadable between humans, with the genetic material of the emerging corona virus, which produces a modified virus that the human body's immune system can fight and defeat.
The results of the vaccine experiments showed that it worked well with the monkeys, which were exposed to intense quantities of the emerging corona virus, which encouraged the university to start its experiment in humans. Last Thursday, the university launched the first clinical trials of a vaccine against Covid-19, and is currently being tested by 550 participants.
The world's largest vaccine production company based in India is preparing to produce millions of doses of the Oxford University vaccine by next month.
"Oxford vaccine" has promising results: it will be ready next September
2020-04-30T00:02:24.915Z
Researchers at the University of Oxford announced that a major leap in the implementation of a vaccine for the Corona virus, stressing that the vaccine may be ready on a large scale by next September. The researchers said that clinical trials on the vaccine against the emerging virus are well under way, indicating that they are
Source: emara